Zhejiang Hisun Pharmaceutical Co Ltd (600267) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.050x

Based on the latest financial reports, Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥438.43 Million ≈ $64.16 Million USD) by net assets (CN¥8.76 Billion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang Hisun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Zhejiang Hisun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Zhejiang Hisun Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.

Zhejiang Hisun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Hisun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Veeco Instruments Inc
NASDAQ:VECO
0.018x
Shenzhen Rongda Photosensitive & Technology Co Ltd
SHE:300576
0.035x
Westone Information Industry Inc
SHE:002268
-0.034x
Schiehallion Fund Ltd
LSE:MNTN
-0.004x
AMP Limited
F:AMP
-0.012x
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
0.077x
Ocular Therapeutix Inc
NASDAQ:OCUL
-0.083x
Triumph Group Inc
NYSE:TGI
-1.931x

Annual Cash Flow Conversion Efficiency for Zhejiang Hisun Pharmaceutical Co Ltd (1999–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Hisun Pharmaceutical Co Ltd from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see 600267 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥8.58 Billion
≈ $1.26 Billion
CN¥2.11 Billion
≈ $309.42 Million
0.246x +35.66%
2023-12-31 CN¥8.35 Billion
≈ $1.22 Billion
CN¥1.52 Billion
≈ $221.98 Million
0.182x -26.73%
2022-12-31 CN¥8.33 Billion
≈ $1.22 Billion
CN¥2.07 Billion
≈ $302.28 Million
0.248x +4.90%
2021-12-31 CN¥7.35 Billion
≈ $1.07 Billion
CN¥1.74 Billion
≈ $254.11 Million
0.236x +22.79%
2020-12-31 CN¥8.26 Billion
≈ $1.21 Billion
CN¥1.59 Billion
≈ $232.61 Million
0.193x +111.79%
2019-12-31 CN¥7.68 Billion
≈ $1.12 Billion
CN¥698.39 Million
≈ $102.20 Million
0.091x -53.62%
2018-12-31 CN¥7.38 Billion
≈ $1.08 Billion
CN¥1.45 Billion
≈ $211.64 Million
0.196x +24.42%
2017-12-31 CN¥7.88 Billion
≈ $1.15 Billion
CN¥1.24 Billion
≈ $181.55 Million
0.158x +63.23%
2016-12-31 CN¥8.04 Billion
≈ $1.18 Billion
CN¥775.90 Million
≈ $113.54 Million
0.097x +7.05%
2015-12-31 CN¥8.17 Billion
≈ $1.19 Billion
CN¥736.17 Million
≈ $107.72 Million
0.090x +30.49%
2014-12-31 CN¥8.26 Billion
≈ $1.21 Billion
CN¥571.04 Million
≈ $83.56 Million
0.069x -21.92%
2013-12-31 CN¥5.96 Billion
≈ $871.87 Million
CN¥527.25 Million
≈ $77.15 Million
0.088x +22.41%
2012-12-31 CN¥5.20 Billion
≈ $760.59 Million
CN¥375.75 Million
≈ $54.98 Million
0.072x -36.79%
2011-12-31 CN¥4.59 Billion
≈ $672.18 Million
CN¥525.31 Million
≈ $76.87 Million
0.114x -38.37%
2010-12-31 CN¥2.74 Billion
≈ $401.57 Million
CN¥509.18 Million
≈ $74.51 Million
0.186x -4.62%
2009-12-31 CN¥2.43 Billion
≈ $355.67 Million
CN¥472.85 Million
≈ $69.19 Million
0.195x +36.20%
2008-12-31 CN¥1.55 Billion
≈ $226.70 Million
CN¥221.28 Million
≈ $32.38 Million
0.143x -55.07%
2007-12-31 CN¥1.38 Billion
≈ $201.50 Million
CN¥437.72 Million
≈ $64.05 Million
0.318x +273.86%
2006-12-31 CN¥1.27 Billion
≈ $185.92 Million
CN¥108.03 Million
≈ $15.81 Million
0.085x -8.03%
2005-12-31 CN¥1.23 Billion
≈ $179.69 Million
CN¥113.53 Million
≈ $16.61 Million
0.092x -64.49%
2004-12-31 CN¥1.20 Billion
≈ $175.90 Million
CN¥312.93 Million
≈ $45.79 Million
0.260x -9.59%
2003-12-31 CN¥1.00 Billion
≈ $146.59 Million
CN¥288.45 Million
≈ $42.21 Million
0.288x +96.58%
2002-12-31 CN¥824.83 Million
≈ $120.70 Million
CN¥120.82 Million
≈ $17.68 Million
0.146x +66.14%
2001-12-31 CN¥784.18 Million
≈ $114.75 Million
CN¥69.14 Million
≈ $10.12 Million
0.088x +19.97%
2000-12-31 CN¥757.90 Million
≈ $110.90 Million
CN¥55.70 Million
≈ $8.15 Million
0.073x -43.75%
1999-12-31 CN¥249.88 Million
≈ $36.56 Million
CN¥32.64 Million
≈ $4.78 Million
0.131x --

About Zhejiang Hisun Pharmaceutical Co Ltd

SHG:600267 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.03 Billion
CN¥13.85 Billion CNY
Market Cap Rank
#6297 Global
#1422 in China
Share Price
CN¥11.55
Change (1 day)
-0.60%
52-Week Range
CN¥8.75 - CN¥12.66
All Time High
CN¥20.23
About

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss… Read more